Christian Rommel, PhD

Executive Vice President, Global Head of Research & Development and Member of the Pharmaceuticals Leadership Team at Bayer AG

Dr. Rommel has served on the Askbio Board of Directors since 2021. He is the Executive Vice President, Global Head of Research & Development and Member of the Pharmaceuticals Leadership Team at Bayer, a role he has held since February 2021. From January 2014 to February 2021, Dr. Rommel served in various positions at Roche, culminating in his role as Senior Vice President, Global Head of Pharma Research and Early Development (pRED) Oncology. Prior to this, Dr. Rommel worked at Amgen where he held roles including Vice President of External Research and Development and Vice President, Research Oncology. Previously, he served as Chief Scientific Officer of Intellikine, a private biotech, from its inception to its acquisition by Takeda Pharmaceuticals.

Dr. Rommel also contributes to the Board of Directors for BlueRock Therapeutics, Vividion Therapeutics, and CRISPR Therapeutics. He also serves on the Board of Trustees for the Max Planck Institute for Molecular Genetics.

Dr. Rommel received his PhD in Molecular Oncology from the Max Planck Institute in Berlin, Germany, and the Institute of Medical Virology at the University of Zurich, Switzerland. In addition to his leadership roles, he lectured on biotechnology at the ETH Zurich, Switzerland, for several years. He has authored more than 70 publications, including papers in Science and Nature.